首页> 外国专利> lymphotoxin, but actually nukleinsaeure, nukleinsaeure containing vectors and transformed cells, method of lymphotoxin and lymphotoxin neutralizing antikoerper.

lymphotoxin, but actually nukleinsaeure, nukleinsaeure containing vectors and transformed cells, method of lymphotoxin and lymphotoxin neutralizing antikoerper.

机译:淋巴毒素,但实际上是核纽蛋白,含有载体和转化细胞的核纽蛋白,淋巴毒素和淋巴毒素的方法中和了抗铜蛋白。

摘要

Lymphotoxin (I) absolutely free from homologous proteins that are unidentified or present in unknown amounts is new. Unglycosylated (I) is new. Variant (I) in which an amino acid residue in the (I) sequence has been deleted or substd. by another residue, or in which another residue has been inserted, is new. Provided that (I) having a sequence with an amino terminal at Leu(+)1 or His(+)23 is excluded. Nucleic acid encoding (I) and selected from (a)-(c) is new. (a) DNA encoding (I) free from DNA encoding other proteins of the organism from which the DNA originated; (b) DNA encoding (I) free from untranslated intervening sequences; and (c) nucleic acid capable of hybridising to nucleic acid encoding (I), provided that the acid does not have the nucleotide sequence of natural DNA or RNA encoding (I).
机译:绝对不含未知蛋白或未知数量的同源蛋白的淋巴毒素(I)是新的。未糖基化(I)是新的。变体(I),其中(I)序列中的氨基酸残基已被缺失或取代。另一个残基或已插入另一个残基的术语是新的。前提是(I)具有在Leu(+)1或His(+)23具有氨基末端的序列的被排除。编码(I)并选自(a)-(c)的核酸是新的。 (a)编码(I)的DNA,不含编码该DNA来源的生物体其他蛋白质的DNA; (b)编码(I)的DNA不含未翻译的插入序列; (c)能够与编码(I)的核酸杂交的核酸,条件是该酸不具有编码(I)的天然DNA或RNA的核苷酸序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号